Onyx Healthcare Inc. (TPEX:6569)
Taiwan · Delayed Price · Currency is TWD 96.10
+2.20 (2.34%)
At close: Mar 6, 2026
Onyx Healthcare Revenue
In the year 2025, Onyx Healthcare had annual revenue of 1.31B TWD with 5.80% growth. Onyx Healthcare had revenue of 315.74M in the quarter ending December 31, 2025, a decrease of -17.47%.
Revenue
1.31B
Revenue Growth
+5.80%
P/S Ratio
2.86
Revenue / Employee
10.94M
Employees
120
Market Cap
3.75B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.31B | 72.04M | 5.80% |
| Dec 31, 2024 | 1.24B | -251.61M | -16.85% |
| Dec 31, 2023 | 1.49B | -107.41M | -6.71% |
| Dec 31, 2022 | 1.60B | 398.51M | 33.16% |
| Dec 31, 2021 | 1.20B | -145.54M | -10.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lotus Pharmaceutical | 18.66B |
| PharmaEssentia | 15.63B |
| Nang Kuang Pharmaceutical | 2.16B |
| Bionime | 1.91B |
| Easywell Biomedicals | 588.89M |
| Genovate Biotechnology | 492.41M |
| Intech Biopharm | 113.85M |
| ACRO Biomedical | 36.50M |